i have alot of shares guys and love the company. Whats your

New Post Public Reply Private Reply Replies (2) Message Board
stockplayer

i have alot of shares guys and love the company. Whats your guys take on this post on ihub he is really respected on ihub just curious thanks

Shares issued to Ironridge at 70% of the market price plus processing fees equal to 11% of the amount borrowed from Ironridge is a better funding deal than most other short term toxic penny stock financing deals?

Hardly.

It is still a very toxic deal that amounts to hundreds of millions of super discounted free trading stock and high interest rates (in this case processing fees).


Ironridge is still due approximately $519,643.74 from the first round of $643,134 in financing they provided and that is after already receiving 143,500,000 shares towards that debt. That means a few hundred million more free trading shares of RFMK stock will get issued to Ironridge to get dumped into the market.

When Ironridge finishes dumping their 143,500,000 free trading shares they got on September 19th and comes calling for their next big round of shares they are going to want the RFMK share price to be as low as possible so that they will have more opportunity for profits. Just like they want the share price to be as high as possible while they are selling their shares. It is all about profiting as much as possible for Ironridge. That means the biggest part of the Ironridge dumping will happen right before they put in their request for their next round of approximately 145,000,000+ free trading shares.

Their financing agreement prevents them from shorting RFMK to drive the price down, but it doesn't prevent them from using heaving dumping on the back end to position the share price for them to get more RFMK shares for their money for the next round of dumping.

This is a must read post about how the financing deal works

http://investorshub.advfn.com/boards/read_msg...d=80277315


Ironridge cannot provide $2.2 million in financing without doing an S-1 filing. The Form D 504 exemption only covers up to $1,000,000 in financing. Since $195,000 of that financing was already used up before the Ironridge deal that means the most RFMK will be able to borrow from Ironridge is $805,000. That is actually good news for the RFMK shareholders because bottom line is that this is a very toxic financing agreement that will cause hundreds of millions of shares to be diluted into the market (possibly over 1 billion shares if the full $805,000 is borrowed).

That makes the latest PR about $2.2 in funding mostly just hype to help pump the share price. Just like the 10K that will never happen (all hype to pump the share price).


I'm curious what makes the Ironridge/RFMK 504 offering any different than the toxic 504 offerings that TJ Management and Fairhills used to get discounted free trading stock in pink sheet companies that recently landed them in SEC litigation (links below)

http://www.sec.gov/news/press/2012/2012-165.htm

http://sec.gov/litigation/complaints/2012/com...12-165.pdf

http://www.sec.gov/litigation/complaints/2012/comp22452.pdf

Fact is that it isn't any different. It is illegal.


Here is a great article published by an experienced SEC attorney that explains why 504 stock is almost never legally free trading.

http://www.securitieslawyer101.com/the-rule-504-myth/

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Occidental Bets Big on Argentine Sunflower Boom

Updated Category News Views 4

The Sunflower Seed Gamble When a company like Occidental Resources plunks down $200 million for sunflower seeds, you sit up and take notice. We're talking 300,000 metric tons of those little yellow gems sourced from Argentina, which according to the Rosario Board of Trade, is rolling in a whopping 6.6 million metric tons of sunflower product this year. Doesn't sound like...

Continue Reading
Cracking Down on Insider Trading: Legal vs Illegal

Updated Category News Views 8

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

Continue Reading
Chicago Nurses Fight for Unionization Amid Tensions

Updated Category News Views 7

Nurses in Chicago Make a Stand for Union Representation When healthcare workers start flexing their collective power, it signals brewing trouble not just for management but the entire system. Those nurses over at Endeavor Health in Chicago are fed up, and, frankly, I can’t blame them. On October 23, they’re gathering to make a big move—you know, filing for a union...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
MISO Unveils Major Energy Grid Project in Iowa

Updated Category News Views 7

Ameren's Game Plan in Iowa There's always something cooking in the energy grids, and this time, MISO's picking up the phone to call a heavy-hitting consortium. Ameren Corp, which flies under the NYSE as AEE, teams up with GridLiance and Dairyland Power Cooperative to kickstart an ambitious grid venture in Iowa. Now, if you're a betting trader, you'd want to size up how...

Continue Reading
Ohas Unveils £1.5M Health Clinic in London

Updated Category News Views 3

Ohas Steps into the Healthcare Spotlight Ohas is setting its sights on the UK healthcare scene with a new clinic launching in London come January 2027. This isn’t about throwing another dull clinic into the mix. No, it’s about changing the narrative on how we handle health. Founded by health tech entrepreneur Richard Chambers and NHS GP Dr. Luke Pratsides, Ohas is...

Continue Reading
MiniTool ShadowMaker 5.0: New Cloud Sync Feature

Updated Category News Views 5

Pushing the Boundaries with Cloud Sync Another day, another software upgrade. MiniTool ShadowMaker has jumped to version 5.0, throwing in a new Cloud Sync feature for Google Drive and OneDrive. Now, you might not be jumping out of your chair with excitement just yet, but hear me out. For those who fiddle with Windows backup and file sync often enough to owe Microsoft a...

Continue Reading
CardVault by Tom Brady Expands to Pittsburgh

Updated Category News Views 2

Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...

Continue Reading
MSG Rangers Joining S&P SmallCap 600: Key Moves

Updated Category News Views 7

MSG Rangers Takes Center Ice—In the Market Here we go—MSG Rangers (NYSE: MSGR) is sliding into the S&P SmallCap 600 like a puck on fresh ice, ready to switch places with Arbor Realty Trust (NYSE: ABR) come October 27. Now, that's not just a game changer for MSGR, but also throws some shuffle onto the board for investors in these organizations. We've got Madison Square...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 5

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading

Top 5 Most Recently Viewed Articles

Minerals Technologies Reveals Q3 Call Details and Insights

Updated Category News Views 147

Minerals Technologies Inc. Schedules Third Quarter Conference Call NEW YORK, September 2025 - Minerals Technologies Inc. (NYSE: MTX), a premier technology-driven specialty minerals entity, is excited to announce the forthcoming release of its financial results for the third quarter of the year. These results will be disclosed after market close on a designated Thursday,...

Continue Reading
How a $100 Investment in BALL Stock Could Grow Over Time

Updated Category News Views 58

Understanding the Long-Term Growth of BALL Stock Over the last two decades, Ball Corporation (NYSE: BALL) has proven to be a solid investment choice, outperforming the broader market by an impressive margin. With an average annual return of 9.9%, investors have seen remarkable growth, illustrating the benefits of long-term investing. The Impact of Compounded Returns The...

Continue Reading
Rosedale Federal and CorServ Unveil Advanced Credit Card Solutions

Updated Category News Views 160

Rosedale Federal and CorServ Collaboration Rosedale Federal Savings & Loan Association has entered a significant partnership with CorServ, a pioneer in payment card solutions. This collaboration aims to transform the credit card experience for both its business and consumer clients, making banking more accessible and convenient. With an extensive history dating back to...

Continue Reading
Fotona Welcomes Daniel Larko as New VP & General Manager

Updated Category News Views 215

Fotona Appoints Daniel Larko as Vice President & General Manager Fotona, a renowned name in medical laser technologies for aesthetics, surgery, dermatology, gynecology, and dentistry, has announced the appointment of Daniel Larko as its new Vice President and General Manager for North America. This strategic move marks a significant step in advancing the company’s...

Continue Reading
Iridex Reports Encouraging Q1 2025 Financial Performance

Updated Category News Views 210

Iridex Unveils Early Financial Outcomes for Q1 2025 Iridex Corporation (Nasdaq: IRIX), recognized for its groundbreaking laser-based medical solutions, has reported intriguing preliminary results for the first quarter of 2025. The company specializes in advanced treatments for glaucoma and retinal diseases, making significant strides in the medical field. Overview of...

Continue Reading